TipRanks
Defence Therapeutics (TSE:DTC)
:DTC
Canadian Market
Want to see TSE:DTC full AI Analyst Report?

Defence Therapeutics (DTC) Financial Statements

14 Followers

Defence Therapeutics Financial Overview

Defence Therapeutics's market cap is currently C$26.53M. The company's EPS TTM is C$-0.1075; its P/E ratio is -3.17; Defence Therapeutics is scheduled to report earnings on October 29, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 26Sep 25Jun 24Sep 23Sep 22
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -72.11KC$ -72.34KC$ -90.92KC$ -13.82KC$ 0.00
Operating IncomeC$ -4.99MC$ -3.27MC$ -12.66MC$ -6.55MC$ -3.56M
EBITDAC$ -4.92MC$ -3.13MC$ -12.66MC$ -6.48MC$ 0.00
Net IncomeC$ -6.70MC$ -3.52MC$ -13.19MC$ -6.76MC$ -7.34M
Balance Sheet
Cash & Short-Term InvestmentsC$ 1.88MC$ 1.23MC$ 56.55KC$ 2.79MC$ 506.70K
Total AssetsC$ 6.51MC$ 1.65MC$ 477.75KC$ 3.53MC$ 719.67K
Total DebtC$ 1.72MC$ 1.50MC$ 1.75MC$ 1.75MC$ 0.00
Net DebtC$ -161.32KC$ 271.84KC$ 1.69MC$ -1.05MC$ -506.70K
Total LiabilitiesC$ 3.00MC$ 2.91MC$ 4.06MC$ 1.97MC$ 1.11M
Stockholders' EquityC$ 3.51MC$ -1.26MC$ -3.58MC$ 1.57MC$ -387.56K
Cash Flow
Free Cash FlowC$ -4.76MC$ -3.40MC$ -4.49MC$ -7.72MC$ -6.04M
Operating Cash FlowC$ -4.34MC$ -3.40MC$ -4.29MC$ -7.66MC$ -6.04M
Investing Cash FlowC$ -419.63KC$ 3.60KC$ -203.24KC$ -65.80KC$ 0.00
Financing Cash FlowC$ 5.42MC$ 4.57MC$ 1.76MC$ 10.01MC$ 1.10M
Currency in CAD

Defence Therapeutics Earnings and Revenue History

Defence Therapeutics Debt to Assets

Defence Therapeutics Cash Flow

Defence Therapeutics Forecast EPS vs Actual EPS